title: Determination of plasma leukotrienes in antigen-induced bronchoconstrictive guinea pigs.
abstract: Convenient extraction and radioimmunoassay methods for measurement of leukotrienes C4 and D4 (LTC4 and LTD4) in biological fluids are described. LTC4 or LTD4 in plasma was extracted with acetonitrile, and the extract was washed with dichloromethane then adjusted to pH 3.5 or 6.0, respectively. Each leukotriene was partially purified by using a C18-bonded silica cartridge and quantitated by radioimmunoassay. Amounts of LTC4 and LTD4 in the range of 0.025-1.6 ng could be assayed in plasma. This procedure was employed to examine the increase in plasma LTC4 (0.249 +/- 0.036 ng/ml) and LTD4 (1.399 +/- 0.235 ng/ml) of guinea pigs during intravenous challenge-induced anaphylactic bronchoconstriction, and the suppression of the increase of bronchoconstriction and leukotrienes by the administration of 5-lipoxygenase inhibitors such as E6080 (6-hydroxy-2-(4-sulfamoylbenzyl-amino)- 4,5,7-trimethylbenzothiazole hydrochloride), AA861 (2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone ) and phenidone. On the other hand, LTC4 and LTD4 were not detected in plasma after an inhaled challenge, though significant bronchoconstriction was provoked. It was concluded that the present study validates a new technique for quantitating plasma leukotrienes on the basis of pH and a suitable method for evaluating the pharmacological efficacy of 5-lipoxygenase inhibitors.
authors.affiliation: Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Sakuma
authors.forename: H
authors.initials: H
authors.lastname: Tsunoda
authors.forename: S
authors.initials: S
authors.lastname: Katayama
authors.forename: S
authors.initials: S
authors.lastname: Abe
authors.forename: I
authors.initials: I
authors.lastname: Yamatsu
authors.forename: K
authors.initials: K
authors.lastname: Katayama
mesh_terms: D000280:Administration, Inhalation; D000707:Anaphylaxis / Q000097:blood / Q000188:drug therapy / Q000276:immunology; D000818:Animals; D000941:Antigens / Q000276:immunology; D016227:Benzoquinones / Q000494:pharmacology; D016084:Bronchoconstriction / Q000276:immunology*; D002851:Chromatography, High Pressure Liquid; D006168:Guinea Pigs; D007275:Injections, Intravenous; D007975:Leukotriene B4 / Q000097:blood*; D016859:Lipoxygenase Inhibitors; D008297:Male; D011720:Pyrazoles / Q000494:pharmacology; D011817:Rabbits; D011863:Radioimmunoassay; D013189:SRS-A / Q000097:blood*; D013844:Thiazoles / Q000494:pharmacology
chemical_list: D000941:Antigens; D016227:Benzoquinones; D016859:Lipoxygenase Inhibitors; D011720:Pyrazoles; D013189:SRS-A; D013844:Thiazoles; C064507:E 6080; D007975:Leukotriene B4; C036837:2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone; C015429:phenidone